-+ 0.00%
-+ 0.00%
-+ 0.00%

CONTEXT THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED IN PHASE 1 TRIAL OF CT-202

Reuters·09/09/2026 11:30:00

Please log in to view news